Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Befrits

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical and Experimental Immunology|July 11, 2012
Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel diseaseJ Grundström, L Linton, S Thunberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2006
Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populationsT T H Hoang, A-S Rehnberg, T-U Wheeldon, et al.
Anticancer Research|December 13, 2005
Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidyU Sjöqvist, R Befrits, S Söderlund, et al.
Gut|June 14, 2005
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled studyP Marteau, C S Probert, S Lindgren, et al.
Scandinavian Journal of Gastroenterology|February 1, 1997
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled studyL S Eriksson, R Olsson, H Glauman, et al.
Scandinavian Journal of Gastroenterology|June 1, 1996
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cellsD Grandér, R Hultcrantz, O Weiland, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical and Experimental Immunology|July 11, 2012
Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel diseaseJ Grundström, L Linton, S Thunberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2006
Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populationsT T H Hoang, A-S Rehnberg, T-U Wheeldon, et al.
Anticancer Research|December 13, 2005
Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidyU Sjöqvist, R Befrits, S Söderlund, et al.
Gut|June 14, 2005
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled studyP Marteau, C S Probert, S Lindgren, et al.
Scandinavian Journal of Gastroenterology|February 1, 1997
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled studyL S Eriksson, R Olsson, H Glauman, et al.
Scandinavian Journal of Gastroenterology|June 1, 1996
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cellsD Grandér, R Hultcrantz, O Weiland, et al.
Pageof 5